More Videos
SPECIAL REPORT
MOST SHARED
- Solar Market Heating Back Up?
- Realty Execs See Pain Ahead
- Tommy Lee, Medical Tourism and Nasty Santa, Your Emails
- Keith Bergelt: The Case for Market Based Patent Reform
- Want the Homebuyer's Tax Credit? Here Are Some Tips
- Buying Fear: How to Own Volatility
- Buffett's Berkshire Hathaway Says Net Income Tripled
- Oil Next Week
- Consumers Haven't Changed, They Are Just Pickier
- Can't Find a Job in Your Town? Here Are the Best Places to Look
- Tommy Lee, Medical Tourism and Nasty Santa, Your Emails
- U.S. Markets Gain 3% for the Week Despite 10.2% Unemployment
- Disney's 'Carol' Tests Widest 3-D Release Ever
- Stimulus II? Jobs Tax Credit=Cash For Clunkers
- Rockwell Automation Earnings: What Options Are Saying
- Gold Will Touch Higher Lows and Higher Highs: Analyst
- Is Misery Alive And Well in Your Office?
- Consumers Haven't Changed, They Are Just Pickier
- Watch Foreclosures, Seriously
- Outlook: Dollar Likely to Ride Higher on Bleak Jobs Report
- Holiday Airfare Close to Last Year's and Climbing
- Buffett's Berkshire Hathaway Says Net Income Tripled
- Cramer: Earnings, IPOs Dominate Next Week
- Buying Fear: How to Own Volatility
- Administration Rejects Plan to Buy Fannie Mae Credits
- Consumers Haven't Changed —They Just Got Pickier
- Want the Homebuyer's Tax Credit? Here Are Some Tips
- Fears of Bubble Prompt Investors to Seek Exit Strategy
RSS FEED
Pharma's Market
Text Size 
 |
CNBC.com Roche CFO's presentation at the JPMorgan Healthcare Conference |
] . You'd expect high interest after the "Financial Times" reported last Friday afternoon that the Swiss drugmaker is going to up its bid for Genentech.
Roche CFO Erich Hunziker didn't talk about that. But he did say, "We see very clearly that we will not touch innovation (at Genentech), but there's a lot of synergies we can win in this market."
He acknowledged the "fear" that Roche will "destroy" Genentech [DNA
Loading...
()
] , especially here in the Bay Area where DNA is headquartered, but Hunziker said, "The cuts we will do at the Roche side are much tougher that what we will do at the Genentech side."
 |
CNBC.com Overflow crowd at breakout roche session |
I found it curious that there were three bylines (reporter names) on the FT story, but no attribution whatsoever. No "a source familiar with the situation" or "according to people who are close to the negotiations," etc. I could never go on air without attributing that kind of information even to an anonymous source.
Anyway, Genentech CEO Art Levinson presents tomorrow at 5:30 ET. The company reports earnings after the closing bell this Thursday, so don't expect him to say much here tomorrow. Like Roche, Genentech has been pretty tight-lipped about all this.
At the time of DNA's presentation I will be on "Fast Money" for a live interview with athenahealth CEO Jonathan Bush. ATHN [ATHN
Loading...
()
] is an electronic medical records company that hopes to benefit from President-elect Obama's plan to digitize all the doctors' paperwork.
Questions? Comments?
Data is a real-time snapshot *Data is delayed at least 15 minutes